Clinical Trials Directory

Trials / Unknown

UnknownNCT02492425

A Registry Study on Hospitalized Patients With Community-acquired Pneumonia in Real-life of China

Evaluating the Adherence to Guidelines' Empirical Antibiotic Recommendations and Outcome of Patients Admitted to a Hospital Ward With a Diagnosis of Community-acquired Pneumonia

Status
Unknown
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the disease burden of hospitalized patients with CAP and HCAP in real life of China

Detailed description

In China, the data about current management of patients hospitalized with community acquired pneumonia (CAP) in the real-life setting is not available,type of pneumonia, selection of initial antibiotic, time to clinical stability, antibiotic choice anf modification,clinical outcomes and costs remain unclear. In this study, we will collect comprehensive information on CAP and healthcare associated pneumonia (HCAP) management patterns to evaluate the disease burden of hospitalized patients with CAP and HCAP in real life of China .to analyze microbiological characteristics,clinical manifestations,antibiotic regimens ,adherences to guidelines and effect on outcome in different groups of patients with CAP (\> and = 65 years, different comorbidities ,risk factors) ,to investigate microbiological characteristics,clinical manifestations,antibiotic regimens ,adherences to guidelines and effect on outcome in different groups of disease severity with CAP ,to provide the difference on microbiological characteristics,clinical manifestations,antibiotic regimens ,and outcome between patients with CAP and HCAP ,to understand the current situation of antibiotic regimen ,to evaluate influence of different antibiotic regimens on prognosis.

Conditions

Timeline

Start date
2016-01-01
Primary completion
2016-12-01
Completion
2018-05-01
First posted
2015-07-08
Last updated
2015-10-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02492425. Inclusion in this directory is not an endorsement.